Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

EMU068131

Sigma-Aldrich

MISSION® esiRNA

targeting mouse Myo1b

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
41105324
NACRES:
NA.51

description

Powered by Eupheria Biotech

Quality Level

100

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

GAAAAACAGAGGCCAGCAAGCTCGTCATGTCCTATGTCGCTGCCGTGTGCGGAAAAGGAGCAGAAGTCAATCAGGTCAAGGAACAGCTTCTGCAGTCCAACCCTGTCCTGGAAGCTTTTGGAAATGCCAAGACTGTGAGGAATGACAACTCATCTAGATTCGGCAAATACATGGATATTGAATTTGACTTTAAAGGCGATCCGCTGGGAGGAGTGATAAGTAACTATCTTTTAGAGAAATCTCGTGTTGTTAAGCAGCCAAGAGGTGAAAGAAACTTCCATGTGTTCTATCAGCTGCTCTCAGGCGCCTCTGAGGAGCTCCTCTACAAGCTTAAGCTGGAGCGGGATTTCAGCAGATACAACTATCTGAGTCTGGACTCTGCTAAAGTTAATGGTGTGGATGATGCTGCCAATTTCAGAA

Ensembl | mouse accession no.

ENSMUSG00000018417

NCBI accession no.

NM_010863

shipped in

ambient

storage temp.

−20°C

Gene Information

mouse ... MYO1B(17912) , Myo1b(17912)

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Not finding the right product?  

Try our Product Selector Tool.

Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Bhavana V Chapman et al.
BMC cancer, 15, 861-861 (2015-11-08)
Squamous cell carcinoma of the head and neck (SCCHN) remains a prevalent and devastating disease. Recently, there has been an increase in SCCHN cases that are associated with high-risk human papillomavirus (HPV) infection. The clinical characteristics of HPV-positive and HPV-negative

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service